According to WHO, 150 million people globally are chronic Hepatitis C patients and it claims 500,000 lives annually of which the highest is in China (29.7 million), India (18.2 million), Egypt (11.8 million) and Indonesia (9.43 million). Sofosbuvir (brandname Sovaldi) by Gilead is a direct-acting antiviral (DAA) which is administered orally is highly effective and reduces … [Read more...] about Hepatitis C Drug A Blessing For Indian Generic Pharmaceuticals